Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-014643
Filing Date
2024-02-15
Accepted
2024-02-15 17:29:14
Documents
6
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea193745-6k_alterity.htm 6-K 14784
2 SALES AGREEMENT DATED FEBRUARY 15, 2024 BETWEEN ALTERITY THERAPEUTICS LIMITED AN ea193745ex1-1_alterity.htm EX-1.1 266210
3 OPINION OF QR LAWYERS PTY LTD. ea193745ex5-1_alterity.htm EX-5.1 15580
4 GRAPHIC ex5-1_001.jpg GRAPHIC 22509
5 GRAPHIC ex5-1_002.jpg GRAPHIC 32071
6 GRAPHIC ex5-1_003.jpg GRAPHIC 5696
  Complete submission text file 0001213900-24-014643.txt   381163
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 24644971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)